display
This was announced by the Italian-Russian Chamber of Commerce.
This paves the way for the construction of the first Sputnik-V plant in Europe.
Production should start in June.
Ten million doses of the vaccine could be produced in Italy by the end of the year.
Sputnik V has not yet been approved in the EU, but it is already being used by Hungary, and the Czech Republic is also planning to do so.
The developers of Sputnik-V have criticized the European Medicines Agency EMA.
"We demand a public apology from Christa Wirthumer-Hoche from the EMA because of her negative comments on the direct approval of Sputnik V in EU countries," wrote the vaccine researchers on Tuesday on the online service Twitter.
The chairwoman of the EMA board of directors had described the premature use of the Russian vaccine before EU-wide approval as “Russian roulette”.
"Your remarks raise serious questions about possible political interference in the ongoing EMA investigation," wrote the Russian researchers.
Sputnik V has already been approved by 46 countries.
display
Last week the EU started a process for approval of the Russian vaccine.
However, Hungary had already started to inoculate Sputnik V in mid-February.
Other EU countries, including the Czech Republic and Slovakia, want to follow suit.